Today

Agents

Chat

Arena

Discover

More

App

Coherus Oncology Q2 Net Income USD -20.631 Million - CHRS News | Rallies

Coherus Oncology Q2 Net Income USD -20.631 Million

CHRS•2026-08-05

Q2 financial results

Aug. 5 (Reuters) - Coherus Oncology Q2 sales were USD 14.307 million vs. IBES estimate of USD 14.4 million.

Q2 adjusted net income was USD -30.139 million vs. IBES estimate of USD -25.4 million
Q2 operating income was USD -32.331 million

Related News

Bumble forecasts downbeat quarterly revenue as paying users drop

BMBL•2026-08-05

Ferguson declares quarterly dividend of $0.89 a share

FERG•2026-08-05

Compass Pathways grants new-hire inducement equity awards at USD 11.25 per share

2026-08-05

Orion Q2 FY26 net income falls 80% to $1.8 million; net sales rise 7% to $500.9 million

OEC•2026-08-05

Encompass Health raises 2026 adjusted EPS outlook to $6.02-$6.25

EHC•2026-08-05